Concepedia

Author

Charles W. Riggs

National Cancer Institute

Also Known As

C Riggs, C W Riggs, C. Riggs, C. W. RIGGS, C. W. Riggs, C.W. Riggs, Charles Riggs, Charles W. Riggs, Charles Warburton Riggs

64

Publications

2.2K

Citations

24

H-Index

82

Concepts

All Affiliations

National Cancer InstituteData Management Services (United States)Frederick National Laboratory for Cancer ResearchGenesis LaboratoriesScience Applications International Corporation (United States)
CW

About

Charles W. Riggs is an author at National Cancer Institute specializing in medicine, toxicology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

33

1.4K

2

Health Sciences

4

4

215

3

Natural Sciences

3

3

67

4

Allergy

3

3

47

5

Public Health

1

1

57

Charles W. Riggs

×

44

Publications

2.1K

Citations

24

H-Index

YearCitations

Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and Monkeys

Ofelia A. Olivero, Stuart H. Yuspa, Miriam C. Poirier,

JNCI Journal of the National Cancer Institute

1997

226

Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site.

Michael P. Waalkes, Sabine Rehm, Charles W. Riggs,

PubMed

1988

160

Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice

J M Ward, James Mahmud Rice, Donald A. Creasia,

Carcinogenesis

1983

138

Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis

Isaiah J. Fidler, Douglas M. Gersten, Charles W. Riggs

Cancer

1977

124

Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site.

Michael P. Waalkes, Sabine Rehm, Charles W. Riggs,

PubMed

1989

103

Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.

Zhang-qun Chen, Robert J. Fisher, Charles W. Riggs,

PubMed

1997

96

Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal Antibody

Jane Pearson, William E. Fogler, K Völker,

JNCI Journal of the National Cancer Institute

1991

81

Nickel(II)-mediated oxidative DNA base damage in renal and hepatic chromatin of pregnant rats and their fetuses. Possible relevance to carcinogenesis

Kazimierz S. Kasprzak, Bhalchandra A. Diwan, Jerry M. Rice,

Chemical Research in Toxicology

1992

78

Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase, an Antitumor Ribonuclease

Susanna M. Rybak, John W. Pearson, William E. Fogler,

JNCI Journal of the National Cancer Institute

1996

74

Multiorgan Transplacental and Neonatal Carcinogenicity of 3′-Azido-3′-deoxythymidine in Mice

Bhalchandra A. Diwan, Charles W. Riggs, Daniel Logsdon,

Toxicology and Applied Pharmacology

1999

70

Page 1